Galangin Exerts Neuroprotective Effects in Spinal Cord Injury by Targeting the PI3K / AKT and JAK2 / STAT1 Pathways
Open Access
- 10 November 2026
- journal article
- Published by Wiley in Phytotherapy Research
Abstract
Spinal cord injury (SCI) often leads to permanent neurological deficits, with no effective treatment currently available. Galangin is a naturally occurring flavonoid with anti‐inflammatory and antiapoptotic activities; nevertheless, its efficacy, and molecular mechanisms in SCI remain unelucidated. First, network pharmacology and Gene Expression Omnibus database analyses were used to predict target molecules and galangin signaling pathways. In vitro, LPS‐induced immortalized murine microglial (BV‐2) and rat pheochromocytoma (PC12) cells co‐cultured with conditioned medium were used to elucidate the mechanism via western blotting, immunofluorescence, qRT‐PCR, ELISA, flow cytometry, cellular thermal shift assay (CETSA), drug affinity responsive target stability (DARTS), surface plasmon resonance (SPR), and pathway agonist/inhibitor/siRNA rescue assays. In vivo, SCI rat models were established to validate the protective efficacy through behavioral, histological, and western blot analyses. Galangin alleviated pro‐inflammatory polarization and neuroinflammation in BV‐2 microglia through inhibiting the PI3K/AKT pathway. It also diminished neuronal apoptosis and enhanced axonal growth‐associated markers expression in PC12 neurons by inhibiting the JAK2/STAT1 pathway. These mechanisms were further supported experimentally using pathway agonists, inhibitors, and gene knockdown. In rats, galangin improved motor function and reduced neuroinflammation and neuronal damage. In conclusion, galangin simultaneously inhibited both pathways to alleviate neuroinflammation, decrease neuronal damage, and upregulate axonal growth‐associated markers, thereby improving neurological function in SCI. Thus, galangin is a potential protective candidate for SCI.Keywords
Funding Information
- Natural Science Foundation of Xinjiang Uygur Autonomous Region (2026D01C201)
This publication has 35 references indexed in Scilit:
- Pharmacological Diversity of Flavonoids and Their Clinical Application Prospects in Neurological DisordersPhytotherapy Research, 2025
- Galangin Nano‐Cocktail Balances Prodrug Activation and Antitumor Response for Enhanced Cancer TreatmentSmall, 2025
- Unraveling Spinal Cord Injury Nutrition: Effects of Diet on the Host and MicrobiomeAdvances in Nutrition, 2025
- Galangin protects against acute pancreatitis by inhibiting ROS-induced acinar cell apoptosis and M1-type macrophage polarizationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2025
- Mitigation of ischemia/reperfusion injury via selenium nanoparticles: Suppression of STAT1 to inhibit cardiomyocyte oxidative stress and inflammationBiomaterials, 2025
- Targeted microbiota dysbiosis repair: An important approach to health management after spinal cord injuryAgeing Research Reviews, 2024
- Global, regional, and national burden of spinal cord injury from 1990 to 2021 and projections for 2050: A systematic analysis for the Global Burden of Disease 2021 studyAgeing Research Reviews, 2024
- Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implicationsActa Pharmaceutica Sinica B, 2024
- Recent advances on signaling pathways and their inhibitors in spinal cord injuryBiomedicine & Pharmacotherapy, 2024
- TLR4 aggravates microglial pyroptosis by promoting DDX3X‐mediated NLRP3 inflammasome activation via JAK2/STAT1 pathway after spinal cord injuryClinical and Translational Medicine, 2022